Jiahao Meng, Zeya Yan, Xi Tao
Nov 4, 2022
Citations
0
Influential Citations
1
Citations
Quality indicators
Journal
Epilepsia Open
Abstract
Epilepsy is one of the most common and refractory neurological disorders globally. Ganaxolone, a neuroactive steroid that enhances GABAergic inhibition, has been tested in many trials for the resolution of refractory epilepsy. Based on these, our study implemented a meta‐analysis to evaluate the general benefit of ganaxolone for refractory epilepsy.